Investment criteria

We are science led investors, focusing on innovative technologies in areas of high unmet need. With our transatlantic footprint we have deep-routed networks across Europe and North America to source the best opportunities that offer meaningful therapies for patients.


Novel therapeutics with first or best in class approach. We focus on investing in high impact science, with the potential to dramatically improve outcomes for patients.


An experienced team with a proven track record along with established venture capital and biotech networks provide Arix with access to quality deals


Headquartered in London with an office in New York provides access to the best life science innovation across Europe and North America

Development Stage

Guided by the quality of the opportunity with a focus on late pre-clinical to clinical stage companies